These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7881867

  • 1. Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria.
    Harada M, Miyahara T, Kajita-Kondo S, Kozakai A, Higuchi S, Otomo S, Kozuka H.
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):183-93. PubMed ID: 7881867
    [Abstract] [Full Text] [Related]

  • 2. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
    Harada M, Miyahara T, Miyata M, Tomita I, Okayachi H, Ikemoto Y, Higuchi S, Otomo S, Kozuka H, Ikekawa N.
    Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
    Miyahara T, Harada M, Kozakai A, Matsumoto M, Hashimoto K, Inoue H, Yoda K, Nakatsu T, Kajita S, Yamazaki R, Higuchi S, Kozuka H, Nemoto N.
    J Nutr Sci Vitaminol (Tokyo); 1999 Jun; 45(3):239-49. PubMed ID: 10524344
    [Abstract] [Full Text] [Related]

  • 4. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T, Simoura T, Osahune N, Uchida Y, Sakuma T, Nemoto N, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Chiba H, Iba K, Sawada N.
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
    Miyahara T, Gomyo S, Ueda Y, Ohyama Y, Sigeno C, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Yamamoto M, Sakuma T, Nemoto N.
    Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
    Tanaka M, Muramatsu M, Higuchi S, Otomo S.
    Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192
    [Abstract] [Full Text] [Related]

  • 8. Metabolism of 3H-1 alpha,25-dihydroxyvitamin D3 in cultured human keratinocytes.
    Ray S, Ray R, Holick MF.
    J Cell Biochem; 1995 Sep; 59(1):117-22. PubMed ID: 8530531
    [Abstract] [Full Text] [Related]

  • 9. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
    Okuno S, Inaba M, Nishizawa Y, Morii H.
    Miner Electrolyte Metab; 1995 Sep; 21(1-3):211-6. PubMed ID: 7565452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metatarsals cultured in serum-free medium.
    Bagi CM, Miller SC.
    J Bone Miner Res; 1992 Jan; 7(1):29-40. PubMed ID: 1549956
    [Abstract] [Full Text] [Related]

  • 13. Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
    Sato K, Nishii Y, Woodiel FN, Raisz LG.
    Bone; 1993 Jan; 14(1):47-51. PubMed ID: 8443002
    [Abstract] [Full Text] [Related]

  • 14. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG, Redlich K, Schiller C, Chirayath MV, Uskokovic M, Peterlik M, Cross HS.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [Abstract] [Full Text] [Related]

  • 15. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
    Astecker N, Bobrovnikova EA, Omdahl JL, Gennaro L, Vouros P, Schuster I, Uskokovic MR, Ishizuka S, Wang G, Reddy GS.
    Arch Biochem Biophys; 2004 Nov 15; 431(2):261-70. PubMed ID: 15488475
    [Abstract] [Full Text] [Related]

  • 16. Disposition and metabolism of F6-1alpha,25(OH)2 vitamin D3 and 1alpha,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds.
    Komuro S, Sato M, Kanamaru H.
    Drug Metab Dispos; 2003 Aug 15; 31(8):973-8. PubMed ID: 12867483
    [Abstract] [Full Text] [Related]

  • 17. 1,25-Dihydroxyvitamin D3 metabolism in a human osteosarcoma cell line and human bone cells.
    Miller BE, Chin DP, Jones G.
    J Bone Miner Res; 1990 Jun 15; 5(6):597-608. PubMed ID: 2166423
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Metabolism of 25-hydroxyvitamin D3 and its regulation in rats during hypokinesis].
    Sergeev IN, Arkhapchev IuP, Linberg LF, Blazheevich NV, Ushakov AS.
    Biokhimiia; 1984 Apr 15; 49(4):590-8. PubMed ID: 6329324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.